Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$0.71 - $2.43 $11,360 - $38,880
-16,000 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$4.45 - $8.09 $8,010 - $14,562
-1,800 Reduced 10.11%
16,000 $76,000
Q3 2021

Oct 29, 2021

SELL
$6.94 - $8.85 $23,249 - $29,647
-3,350 Reduced 15.84%
17,800 $139,000
Q2 2021

Jul 26, 2021

SELL
$7.45 - $16.27 $5,960 - $13,016
-800 Reduced 3.64%
21,150 $171,000
Q1 2021

Apr 27, 2021

BUY
$8.78 - $12.8 $192,721 - $280,960
21,950 New
21,950 $248,000
Q4 2020

Jan 25, 2021

SELL
$1.08 - $8.2 $11,232 - $85,279
-10,400 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$0.95 - $1.42 $760 - $1,136
-800 Reduced 7.14%
10,400 $12,000
Q2 2020

Jul 23, 2020

SELL
$0.63 - $1.7 $2,205 - $5,950
-3,500 Reduced 23.81%
11,200 $14,000
Q1 2020

Apr 30, 2020

SELL
$0.67 - $1.85 $1,139 - $3,145
-1,700 Reduced 10.37%
14,700 $10,000
Q4 2019

Jan 21, 2020

SELL
$1.36 - $2.44 $2,040 - $3,660
-1,500 Reduced 8.38%
16,400 $28,000
Q2 2019

Jul 29, 2019

BUY
$1.36 - $2.35 $4,039 - $6,979
2,970 Added 19.89%
17,900 $33,000
Q1 2019

Apr 30, 2019

BUY
$0.78 - $2.01 $78 - $200
100 Added 0.67%
14,930 $30,000
Q4 2018

Feb 01, 2019

BUY
$0.62 - $2.25 $452 - $1,642
730 Added 5.18%
14,830 $10,000
Q3 2018

Nov 05, 2018

SELL
$1.38 - $1.94 $4,857 - $6,828
-3,520 Reduced 19.98%
14,100 $25,000
Q2 2018

Jul 24, 2018

BUY
$1.73 - $3.35 $30,482 - $59,027
17,620 New
17,620 $30,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.